PrEP for your Patients' Needs: The PCP's Role in Preventing HIV 2017
Each year approximately 50,000 people in the U.S. will become infected with HIV. To prevent infection, especially in high risk groups, the FDA approved pre-exposure prophylaxis (PrEP), and in 2014 the USPHS/CDC created clinical practice guidelines for the use of PrEP. This presentation discusses the recent USPHS/CDC guidelines in addition to ways clinicians can facilitate open patient-provider dialog, education, and engagement in PrEP. This presentation also discusses universal HIV-screening, in addition to establishing risk for HIV acquisition, determining PrEP eligibility, assessing patients’ PrEP readiness, and counseling patients on PrEP efficacy, safety, and treatment-adherence.